ncponc_2005_169.indd
brb.nci.nih.gov · 1,558 words · saved by 1 readers
N/A
VIEWPOINT www.nature.com/clinicalpractice/onc The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens Richard Simon* and Larry Norton R Simon is Chief Successful treatment of bacterial infections integrated drug effect, the chance of eradi- of the Biometric is largely a result of our ability to exploit the cating the tumor is maximized by delivering Research Branch…
saved by
related reading
- Summing up cancer stem cellsnature.com
- A Mathematical Theory of Communicationpeople.math.harvard.edu
- Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than othersgwern.net
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Ethical Issues in the Development of Oncology Drugs - Hematology & Oncologyhematologyandoncology.net
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanomanature.com
- The History of Medical Oncology in Europe, 1955–1985 - The ASCO Postascopost.com
- Cancersytse.com
- Research advances in treatment strategies for breast cancer liver metastases: A comprehensive review - PMCpmc.ncbi.nlm.nih.gov
- Immunotherapy for Cancer - NCIcancer.gov
- Cancer cells have distinct electrical properties that predict a susceptibility to lipophilic anions; a new cancer drug paradigm | bioRxivbiorxiv.org
- nn-notes.pdfboris-hanin.github.io